Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs

Author:

Zhang Kun,Wang Lijie,Peng Jiayan,Sangji Kangzhuo,Luo Yuting,Zeng Yujiao,Zeweng Yongzhong,Fan Gang

Abstract

The Coronavirus Diseases 2019 (COVID-19) has been rapidly spreading globally and has caused severe harm to the health of people and a substantial social burden. In response to this situation, experts around the world have considered various treatments, including the use of traditional medicine. Traditional Tibetan medicine (TTM), one of the traditional medicines in China, has played an important role in the treatment of infectious diseases in history. It has formed a solid theoretical foundation and accumulated rich experience in the treatment of infectious diseases. In this review, we provide a comprehensive introduction to the basic theory, treatment strategies, and commonly used drugs of TTM for the treatment of COVID-19. In addition, the efficacies and potential mechanisms of these TTM drugs against COVID-19 are discussed based on available experimental data. This review may provide important information for the basic research, clinical application and drug development of traditional medicines for the treatment of COVID-19 or other infectious diseases. More pharmacological studies are needed to reveal the therapeutic mechanisms and active ingredients of TTM drugs in the treatment of COVID-19.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference85 articles.

1. Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines;Ang;Integr. Med. Res.,2020

2. Computational screening of plant-derived natural products against SARS-CoV-2 variants;Ansari;Future Pharmacol.,2022

3. Geranii herba as a potential inhibitor of SARS-CoV-2 main 3CL(pro), spike RBD, and regulation of unfolded protein response: An in silico approach;Arokiyaraj;Antibiot. (Basel),2020

4. Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases;Bai;Biomed. Pharmacother.,2021

5. Treatment of acute upper respiratory tract infection (Chiba Disease) with Tibetan medicine Cui Tang Granules clinical observation of 110 cases;Basang;J. Clin. Med.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3